A limitation of this study is that the exact molecular events leading to the hyper-responsiveness of the non-canonical inflammasome remain elusive, and clinical data are currently insufficient to assess whether patients suffering from SPG11 or SPG48 are prone to infection-related complications. The gene discussed is SPG11; the disease is infection.